Overview
Blepharophimosis-epicanthus inversus-ptosis (BPES) due to copy number variations is an obsolete Orphanet entry (Orphanet code 261579) that was previously used to classify cases of Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome (BPES) specifically caused by chromosomal copy number variations (deletions or duplications) involving the FOXL2 gene region on chromosome 3q23. This condition has since been reclassified and merged into the broader BPES entity. BPES is a rare congenital condition primarily affecting the eyes and eyelids, characterized by four major features: blepharophimosis (narrowing of the horizontal eyelid opening), ptosis (drooping of the upper eyelids), epicanthus inversus (skin folds arising from the lower eyelids), and telecanthus (increased distance between the inner corners of the eyes). BPES exists in two forms: Type I, which includes premature ovarian insufficiency leading to female infertility, and Type II, which involves only the eyelid features without ovarian dysfunction. In cases attributed to copy number variations, the genetic mechanism involves deletions or duplications encompassing or disrupting the FOXL2 gene or its regulatory regions, rather than point mutations within the gene itself. The condition is typically inherited in an autosomal dominant pattern, though de novo copy number changes can also occur. Management of BPES generally involves surgical correction of the eyelid abnormalities, usually performed in early childhood to improve vision and cosmetic appearance. For women with Type I BPES, reproductive counseling and fertility management may be necessary. Because this Orphanet entry is now obsolete, patients and clinicians should refer to the main BPES classification (Orphanet code 126) for current clinical and genetic information.
Also known as:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
1 eventCytalux: FDA approved
As an adjunct for intraoperative identification of malignant lesions in adult patients with ovarian cancer
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesCytalux
On Target Laboratories, LLC
Cytalux — Contact On Target Laboratories, LLC
Travel Grants
No travel grants are currently matched to OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations.
Start the conversation →Latest news about OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations
No recent news articles for OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations
What is OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations?
Blepharophimosis-epicanthus inversus-ptosis (BPES) due to copy number variations is an obsolete Orphanet entry (Orphanet code 261579) that was previously used to classify cases of Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome (BPES) specifically caused by chromosomal copy number variations (deletions or duplications) involving the FOXL2 gene region on chromosome 3q23. This condition has since been reclassified and merged into the broader BPES entity. BPES is a rare congenital condition primarily affecting the eyes and eyelids, characterized by four major features: blepharophimosis (narr
How is OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations inherited?
OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations typically begin?
Typical onset of OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations is neonatal. Age of onset can vary across affected individuals.
What treatment and support options exist for OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations?
1 patient support program are currently tracked on UniteRare for OBSOLETE: Blepharophimosis-epicanthus inversus-ptosis due to copy number variations. See the treatments and support programs sections for copay assistance, eligibility, and contact details.